Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharma4ever A/S
A/S
Active
Advertising protection
CVR 36436573
Hørkær 24, 2730
Herlev
Engineering activities and related technical consultancy
·
NACE 7112
Est. 2014 · 11 years old
17 employees
www.pharma4ever.com
Monitor
Share
Denmark
/
Companies
/
Engineering activities and related technical consultancy
/
Pharma4ever A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
20M
15M
10M
5M
0M
9M
2021
13M
+44%
2022
15M
+15%
2023
15M
0%
2024
16M
+7%
2025
EBITDA
DKK millions
6M
5M
3M
2M
0M
2M
2021
3M
+50%
2022
5M
+67%
2023
3M
-40%
2024
3M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
8.911
13.010
15.279
15.476
16.333
Staff expenses
-6.676
-9.565
-10.203
-12.368
-12.850
EBITDA
2.235
3.445
5.076
3.108
3.483
Depreciation & amort.
-41
-25
-0
-0
-0
EBIT
2.194
3.420
5.075
3.108
3.483
Net financials
-3
-12
-3
-5
1
Profit before tax
2.191
3.408
5.073
3.102
3.484
Tax
485
753
1.129
686
769
Net profit
1.706
2.655
3.944
2.416
2.715
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
4.875
6.251
9.779
8.762
9.734
Equity
2.329
3.235
4.528
2.916
3.215
Long-term debt
0
0
0
0
0
Short-term debt
2.543
3.011
5.245
5.845
6.519
Total debt
2.543
3.011
5.245
5.845
6.519
Financial ratios
5-year trend
EBITDA margin (of gross profit)
21.3%
This company
2021
2025
Equity ratio
33.0%
This company
38.2%
Market median
14% below market
2021
2025
Return on equity
84.4%
This company
18.4%
Market median
359% above market
2021
2025
Net profit margin (of gross profit)
16.6%
This company
2021
2025
Asset turnover (of gross profit)
1.68×
This company
2021
2025
Debt / equity
2.03×
This company
0.62×
Market median
227% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Pharma4ever A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
